Term Sheet Guide for Founders: What to Negotiate in 2026

A term sheet is a mostly non-binding summary of a proposed venture investment: valuation, amount, investor rights and governance. In our view, the terms most worth a founder's negotiating time are the pre-money valuation and option pool, liquidation preference, anti-dilution, board composition and protective provisions. Economics look founder-friendly in 2026: Cooley's Q2 2026 report found 95.8 percent of deals used a 1x liquidation preference.

The same report found 96.4 percent of deals used non-participating preferred stock, so anything harsher is usually worth a question. This guide covers each term from the founder's side, with worked examples; for how investors think about the same clauses, see term sheets from the investor's side.

Definition: A term sheet is a short document, often just a few pages, that sets out the price and terms of a priced equity round and becomes the blueprint for the definitive financing documents.

The valuation is the number you'll tell people. The rest of the page decides what it's worth and who's in charge.

What a term sheet is (and what is binding)

Most of a term sheet is non-binding: either side can walk away before the definitive documents are signed. A few provisions usually are binding, typically confidentiality, exclusivity (a "no-shop" period during which you cannot negotiate with other investors), and sometimes expense reimbursement. Cooley GO notes that exclusivity is often the one binding part of a term sheet and suggests 30 to 45 days is plenty of time to finalize a venture investment.

Signing starts legal diligence and document drafting. It isn't the finish line, but renegotiating later tends to be costly, so get the details right now. The definitive documents that follow usually build on the National Venture Capital Association's model forms, which are walked through in venture capital deal documents explained.

When founders see term sheets

You will see a term sheet in any priced equity round:

Seed rounds led by institutional funds.
Series A, Series B, and later rounds.
Some bridge rounds structured as preferred equity.

If you raise on SAFEs or convertible notes, there is often no formal term sheet, though some investors send a one-page summary of the cap, discount, and side letter rights. See SAFE vs. priced round to decide which structure fits.

Term sheet pricing: valuation and the option pool

These decide how much of the company you sell.

Pre-money valuation: the company's value before the new money.
Investment amount: how much the investors put in.
Post-money valuation: pre-money plus the investment. Investor ownership equals investment divided by post-money.
Option pool: shares reserved for future hires. Investors usually ask for the pool to be created or topped up before the round, so its dilution falls entirely on existing holders.

Worked example: the option pool shuffle

In an illustrative case, an investor offers $2M at an $8M pre-money valuation ($10M post), with a 10 percent post-money option pool included in the pre-money.

Investor ownership: $2M / $10M = 20 percent.
New pool: 10 percent of the post-money, or $1M of value, carved out of the $8M pre-money.
Existing holders keep 70 percent, so the effective pre-money valuation for founders is $7M, not $8M.

An $8M headline. A $7M reality.

For context, HSBC Innovation Banking's Term Sheet U.S. Financings Guide (May 2026, 500+ signed US deals) found that two thirds of rounds create or expand the employee pool, most commonly at 10 to 20 percent. Carta's option pool guide cites HSBC's separate, UK-focused Venture Capital Term Sheet Guide 2026 (643 of its 711 term sheets were for UK-headquartered companies): in those deals pools most often run 10 to 15 percent of the company, 10 percent is the most frequent size, and 71 percent of term sheets created or topped up a pool.

Our preferred counter is to size the pool to a hiring plan for the next 12 to 18 months rather than a round number. The option pool strategy guide shows how.

Economic rights: who gets paid in an exit

Liquidation preference. Investors get their money back before common stockholders in a sale or wind-down. The common market term is 1x non-participating: investors take the greater of their money back or what they would receive by converting to common. Participating preferred lets investors take their money back and share in what is left, and multiples above 1x (2x, 3x) push more value to investors.
Anti-dilution protection. Adjusts the investor's conversion price if you later raise at a lower price. Broad-based weighted average is the common approach and softens the impact. Full ratchet resets the conversion price to the new, lower price regardless of how many shares were sold. Cooley GO describes it as far less common in US venture deals than broad-based weighted average, so we'd treat it as a red flag.
Dividends. Usually non-cumulative and paid only if declared. Cooley reports accruing dividends in just 3 percent of Q2 2026 deals.
Pro rata rights. The right to invest in future rounds to maintain ownership.
Pay-to-play. Requires existing investors to invest in future rounds or lose some preferred rights. Cooley found it in 8.4 percent of Q2 2026 deals, up from 7 percent in Q1.

Worked example: preference math at exit

In this illustrative example, investors put in $10M for 25 percent, with a 1x preference.

Exit value	1x non-participating	1x participating
$20M	$10M (takes preference)	$10M + 25% of $10M = $12.5M
$100M	$25M (converts)	$10M + 25% of $90M = $32.5M

At a $100M exit, participation moves $7.5M from common holders, including founders and employees, to investors. The investor-side liquidation preference guide walks through more cases.

Control and governance rights

Economics decide how much you make. Control decides whether you get to keep making the calls. How much you trade of each is a real choice, and we've written about the trade-off between control and wealth.

Board composition. Seed boards are often two common seats and one investor seat; Series A boards often add an investor or an independent director. Exact structures vary. Many founders try to keep the common side in control as long as they reasonably can.
Protective provisions. Investor vetoes over major actions, such as selling the company, issuing senior stock, taking on debt, or changing the charter. Standard lists are generally fine. Vetoes over the operating budget or hiring are worth pushing back on.
Right of first refusal and co-sale. Investors (or the company) can buy shares a founder tries to sell, or sell alongside them.
Drag-along. Requires all holders to support a sale approved by specified holders. Check that the approval threshold includes common holders and that founders are not asked to give broader representations than other sellers.
Founder vesting. Investors may ask founders to re-vest part of their shares. Credit for time served and acceleration on a change of control are common asks.

What changed in term sheets for 2026

Tranched rounds are now standardized. NVCA's October 2025 model document update added stock purchase agreement language for milestone-based closings, according to Foley & Lardner. If you accept tranches, we'd push for objective, auditable milestones.
National security representations. The same update added representations covering US outbound investment and data security rules, which Foley & Lardner notes matter most for companies in semiconductors, AI or quantum computing, or that handle sensitive data such as genomic, biometric, geolocation or health information.
QSBS language updated. The model documents now reflect the 2025 federal changes to Section 1202, which raised the gross asset threshold to $75M for stock issued after July 4, 2025.
Down rounds have not disappeared. Up rounds were 83.6 percent of Cooley's Q2 2026 deals, but 12.1 percent were down rounds and 4.3 percent were flat, and pay-to-play provisions ticked up. If your round is a recovery round, check for structured terms.

"Terms are standard now, so why negotiate?"

It's a fair question. With 1x non-participating preferred in the vast majority of Cooley's deals, the economics on most term sheets look alike, and fighting over boilerplate can burn goodwill with someone you'll work with for years.

But the headline economics are the part that's standardized. The option pool, the board, the protective provisions and the no-shop still move from deal to deal, and they're where much of the value quietly changes hands. We'd skip the fight over boilerplate and spend the capital on those.

Term sheet red flags and negotiation checklist

Before signing, work through this list with your lawyer:

Is the liquidation preference 1x non-participating? If not, why?
Is anti-dilution broad-based weighted average?
Is the option pool sized to a real hiring plan?
Does the board stay balanced or founder-controlled for this stage?
Are protective provisions limited to major corporate actions?
Are dividends non-cumulative?
Is there redemption, pay-to-play, or a tranche? Do you understand each one?
How long is the no-shop, and does it end if the investor walks?
Have you modeled payouts at $25M, $100M, and $500M exits?
Has a startup lawyer reviewed it? See choosing a startup lawyer.

Leverage comes mostly from alternatives. One of the most effective ways to improve a term sheet is to have a second one, which is why we think founders should run fundraising like a sales pipeline. 1752vc's Accelerate, the flagship program for early-stage startups ready to grow, pairs a $100K investment (at a valuation cap of up to $3.5M) with founder-led sales training and access to a network of 850+ investors, which can widen the set of investors you are talking to when a term sheet arrives.

The bottom line

Most 2026 term sheets are clean on the headline economics. The work is in the pool, the board and the vetoes, and in having a second offer when you sit down to negotiate.

The price gets you the headline.

The terms decide the outcome.

Key takeaways

Most term sheet terms are non-binding, but confidentiality and no-shop clauses usually bind you.
The pre-money option pool lowers your effective valuation; sizing it to a real hiring plan rather than a default percentage can limit that.
A 1x non-participating liquidation preference is the common market term: Cooley's Q2 2026 data shows 1x in 95.8 percent of deals and non-participating preferred in 96.4 percent.
Broad-based weighted average anti-dilution is normal; full ratchet and participating preferred are, in our view, red flags.
It usually helps to protect board balance and limit protective provisions to major corporate actions.
Modeling exit payouts at several values and having a startup lawyer review before signing are worth the time.

Frequently asked questions

Can you negotiate a term sheet after signing it?

You can, but it is costly. Most economic terms are not legally binding until the definitive documents are signed, so changes are possible, yet reopening price or control after signing burns goodwill and can stall the deal. In practice, the most useful window for negotiation is usually before you sign, when you still have alternatives and before the no-shop period starts.

What is the option pool shuffle in a term sheet?

The option pool shuffle is when investors require a new or larger option pool to be counted in the pre-money valuation. The pool's dilution then falls only on existing holders, so the effective price founders receive is lower than the headline valuation. Sizing the pool to a 12 to 18 month hiring plan can limit the effect.

What should founders negotiate in a term sheet?

In our view, the terms to focus on are the pre-money valuation, option pool size, liquidation preference, anti-dilution method, board composition, and protective provisions. Those terms decide your ownership, your payout in an exit, and who controls major decisions. Cooley GO suggests picking about three issues that matter most rather than debating every clause, and leaving boilerplate to the model forms.

What are the biggest red flags in a term sheet?

Terms we would look closely at include participating preferred, liquidation preferences above 1x, full ratchet anti-dilution, cumulative dividends, and protective provisions that reach into budgets or hiring. Also check for founder re-vesting without credit for time served and a board that tips to investor control at seed. Each can be reasonable in context, so it is fair to ask why it is there.

Do SAFEs have term sheets?

Usually not in the same form. A SAFE is a short standard agreement, and the key terms (valuation cap, discount, pro rata side letter) are often summarized in an email or a one-page summary rather than a full term sheet.

Sources

Disclaimer: This guide is for general education only and is not legal, tax or investment advice. Laws, market data and program terms change, so it may not reflect the latest developments or fit your situation. Treat it as a starting point, not a source of truth, and talk to a qualified lawyer, accountant or financial adviser before you make decisions.